Evidence map›Paper›PMID 25378573›Full record

ArticleJournal of clinical microbiology2015

Whole-genome phylogenomic heterogeneity of Neisseria gonorrhoeae isolates with decreased cephalosporin susceptibility collected in Canada between 1989 and 2013.

Walter Demczuk, Tarah Lynch, Irene Martin, Gary Van Domselaar, Morag Graham, Amrita Bharat, Vanessa Allen, Linda Hoang, Brigitte Lefebvre, Greg Tyrrell and 6 more

Abstract readHistorical Article
In one paragraph

Article in Journal of clinical microbiology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 64 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
64citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

64 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Emergence and evolution of mosaicFrontiers in microbiology · 2024
    Article
  7. Article
  8. Review
  9. Review
  10. Prediction of antimicrobial minimal inhibitory concentrations forSaudi journal of biological sciences · 2022
    Article
  11. Review
  12. Comparative Whole-Genome Analysis ofFrontiers in cellular and infection microbiology · 2022
    Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Microbial genomics · 2021
    Article
  19. Article
  20. First National Genomic Epidemiological Study ofFrontiers in microbiology · 2021
    Article

4 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Walter DemczukBacteriology and Enteric Diseases Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada Walter.Demczuk@phac-aspc.gc.ca.
Tarah LynchAlberta Health Services, Calgary, Alberta, Canada.
Irene MartinBacteriology and Enteric Diseases Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada.
Gary Van DomselaarScience Technology Cores and Services Division, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada, and Department of Medical Microbiology, University of Manitoba, Winnipeg, Manitoba, Canada.
Morag GrahamScience Technology Cores and Services Division, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada, and Department of Medical Microbiology, University of Manitoba, Winnipeg, Manitoba, Canada.
Amrita BharatBacteriology and Enteric Diseases Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada.
Vanessa AllenPublic Health Ontario Laboratories, Toronto, Ontario, Canada.
Linda HoangBritish Columbia Public Health Microbiology and Reference Laboratory, British Columbia Centre for Disease Control, Vancouver, British Columbia, Canada.
Brigitte LefebvreLaboratoire de Santé Publique du Québec, Sainte-Anne-de-Bellevue, Québec, Canada.
Greg TyrrellProvincial Laboratory for Public Health, Edmonton, Alberta, Canada.
Greg HorsmanSaskatchewan Disease Control Laboratory, Regina, Saskatchewan, Canada.
David HaldaneQueen Elizabeth II Health Sciences Centre, Halifax, Nova Scotia, Canada.
Richard GarceauDr. G.L. Dumont Hospital, Moncton, New Brunswick, Canada.
John WylieCadham Provincial Laboratory, Winnipeg, Manitoba, Canada.
Tom WongCentre for Communicable Diseases and Infection Control, Public Health Agency of Canada, Ottawa, Ontario, Canada.
Michael R MulveyBacteriology and Enteric Diseases Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A large-scale, whole-genome comparison of Canadian Neisseria gonorrhoeae isolates with high-level cephalosporin MICs was used to demonstrate a genomic epidemiology approach to investigate strain relatedness and dynamics. Although current typing methods have been very successful in tracing short-chain transmission of gonorrheal disease, investigating the temporal evolutionary relationships and geographical dissemination of highly clonal lineages requires enhanced resolution only available through whole-genome sequencing (WGS). Phylogenomic cluster analysis grouped 169 Canadian strains into 12 distinct clades. While some N. gonorrhoeae multiantigen sequence types (NG-MAST) agreed with specific phylogenomic clades or subclades, other sequence types (ST) and closely related groups of ST were widely distributed among clades. Decreased susceptibility to extended-spectrum cephalosporins (ESC-DS) emerged among a group of diverse strains in Canada during the 1990s with a variety of nonmosaic penA alleles, followed in 2000/2001 with the penA mosaic X allele and then in 2007 with ST1407 strains with the penA mosaic XXXIV allele. Five genetically distinct ESC-DS lineages were associated with penA mosaic X, XXXV, and XXXIV alleles and nonmosaic XII and XIII alleles. ESC-DS with coresistance to azithromycin was observed in 5 strains with 23S rRNA C2599T or A2143G mutations. As the costs associated with WGS decline and analysis tools are streamlined, WGS can provide a more thorough understanding of strain dynamics, facilitate epidemiological studies to better resolve social networks, and improve surveillance to optimize treatment for gonorrheal infections.

Indexed as

Cephalosporin ResistanceGenome, BacterialPhylogenyAdolescentAdultAnti-Bacterial AgentsCanadaChildChild, PreschoolFemaleGenotypeGonorrheaHistory, 20th CenturyHistory, 21st CenturyHumansInfantAnti-Bacterial Agents

Identifiers

PMID25378573
PMCPMC4290921

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.